A detailed history of Mariner, LLC transactions in Gamida Cell Ltd. stock. As of the latest transaction made, Mariner, LLC holds 121,482 shares of GMDA stock, worth $3,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121,482
Previous 1,023,164 88.13%
Holding current value
$3,644
Previous $419,000 99.05%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.04 - $0.46 $36,067 - $414,773
-901,682 Reduced 88.13%
121,482 $4,000
Q4 2023

Feb 14, 2024

BUY
$0.25 - $1.02 $73,630 - $300,412
294,522 Added 40.42%
1,023,164 $419,000
Q3 2023

Nov 13, 2023

BUY
$0.85 - $1.87 $475 - $1,045
559 Added 0.08%
728,642 $750,000
Q2 2023

Aug 11, 2023

BUY
$0.73 - $2.37 $3,862 - $12,539
5,291 Added 0.73%
728,083 $1.41 Million
Q1 2023

May 12, 2023

BUY
$0.68 - $1.71 $1,277 - $3,213
1,879 Added 0.26%
722,792 $585,000
Q4 2022

Feb 14, 2023

BUY
$1.15 - $2.1 $5,885 - $10,747
5,118 Added 0.72%
720,913 $930,000
Q3 2022

Nov 10, 2022

BUY
$1.53 - $3.39 $27,939 - $61,904
18,261 Added 2.62%
715,795 $1.14 Million
Q2 2022

Aug 15, 2022

BUY
$1.73 - $4.29 $131,826 - $326,898
76,200 Added 12.26%
697,534 $1.24 Million
Q1 2022

May 13, 2022

BUY
$2.22 - $4.47 $105,643 - $212,713
47,587 Added 8.29%
621,334 $2.58 Million
Q4 2021

Feb 14, 2022

BUY
$2.2 - $4.46 $240,460 - $487,478
109,300 Added 23.53%
573,747 $1.46 Million
Q3 2021

Nov 15, 2021

BUY
$3.85 - $6.44 $399,114 - $667,609
103,666 Added 28.73%
464,447 $1.82 Million
Q2 2021

Aug 24, 2021

BUY
$5.85 - $8.33 $940,568 - $1.34 Million
160,781 Added 80.39%
360,781 $2.31 Million
Q1 2021

May 07, 2021

BUY
$7.8 - $12.43 $1.56 Million - $2.49 Million
200,000 New
200,000 $1.62 Million
Q4 2020

Feb 16, 2021

SELL
$4.07 - $11.0 $455,026 - $1.23 Million
-111,800 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$3.93 - $4.59 $439,374 - $513,162
111,800 New
111,800 $464,000

Others Institutions Holding GMDA

About Gamida Cell Ltd.


  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.